2011Journal of Diseases Monitor & ControlRequires access

The clinical research of treatment of recurrent spontaneous abortion by immunotherapy combined with with HCG and Progesterone

Duan Yu-lin, Li Huawei

Open publisher page 0 citations

Abstract

Objective To compare the clinical effect of treatment the patients with recurrent spontaneous abortion(URSA) by immunotherapy only and immunotherapy combined with HCG and Progesterone,To evaluate the proper therapeutic strategy to treat RSA.Methods 65 cases with primary or secondary RSA were randomly divided into two groups:35cases(group A) were treated with immunotherapy combined with human chorionic gonadotropin (HCG) and Progesterone,30 cases(group B) simply with immunotherapy.Results The rate of successful pregnancy of group A,B were 91.48%,30% respectively.There were significant differences between group A and B(P0.05).Conclusion It is necessary to treat the whole URSA by immunotherapy combined with HCG and Progesterone,Active imm un ization is sa fe and effec tive in treatm ent of unexp la ined recurrent spontaneous abortion,May enhance patient's immunity reactivity,may enhance the curative effect and the pregnancy success ratio,which is worth popu larizing.

About this research paper

What this paper is about

Objective To compare the clinical effect of treatment the patients with recurrent spontaneous abortion(URSA) by immunotherapy only and immunotherapy combined with HCG and Progesterone,To evaluate the proper therapeutic strategy to treat RSA.Methods 65 cases with primary or secondary RSA were randomly divided into two groups:35cases(group A) were treated with immunotherapy combined with human chorionic gonadotropin (HCG) and Progesterone,30 cases(group B) simply with immunotherapy.Results The rate of successful pregnancy of group A,B were 91.48%,30% respectively.There were significant differences between group A and B(P0.05).Conclusion It is necessary to treat the whole URSA by immunotherapy combined with HCG and Progesterone,Active imm un ization is sa fe and effec tive in treatm ent of unexp la ined recurrent spontaneous abortion,May enhance patient's immunity reactivity,may enhance the curative effect and the pregnancy success ratio,which is worth popu larizing.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the clinical effect of treatment the patients with recurrent spontaneous abortion(URSA) by immunotherapy only and immunotherapy combined with HCG and Progesterone,To evaluate the proper therapeutic strategy to treat RSA.Methods 65 cases with primary or secondary RSA were randomly divided into two groups:35cases(group A) were treated with immunotherapy combined with human chorionic gonadotropin (HCG) and Progesterone,30 cases(group B) simply with immunotherapy.Results The rate of successful pregnancy of group A,B were 91.48%,30% respectively.There were significant differences between group A and B(P0.05).Conclusion It is necessary to treat the whole URSA by immunotherapy combined with HCG and Progesterone,Active imm un ization is sa fe and effec tive in treatm ent of unexp la ined recurrent spontaneous abortion,May enhance patient's immunity reactivity,may enhance the curative effect and the pregnancy success ratio,which is worth popu larizing.

Key concepts: Medicine, Active immunotherapy, Immunotherapy, Abortion, Human chorionic gonadotropin, Pregnancy, Gynecology, Obstetrics

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical research of treatment of recurrent spontaneous abortion by immunotherapy combined with with HCG and Progesterone — Research Paper | ScholarLens